Breaking Finance News

Zacks Investment Research upgraded Fresenius SE (NASDAQ:FSNUY) to Hold in a report released today.

Yesterday Fresenius SE (NASDAQ:FSNUY) traded -0.29% lower at $21.82. The company’s 50-day moving average is $20.87 and its 200-day moving average is $20.89. The last stock close price is up 0.29% from the 200-day moving average, compared to the S&P 500 which has increased 0.04% over the same time. 12,900 shares of the stock were exchanged, down from an average trading volume of 22,375

Zacks Investment Research has upgraded Fresenius SE (NASDAQ:FSNUY) to Hold in a report released on 6/21/2017.

See Chart Below

Fresenius SE (NASDAQ:FSNUY)

Fresenius SE has a 52 week low of $17.22 and a 52 week high of $22.30 The company’s market cap is currently $0.

About Fresenius SE (NASDAQ:FSNUY)

Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure. This segment offers dialyzers, dialysis machines, and renal pharmaceuticals, as well as dialysis- related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs comprising intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing whole blood and blood components, as well as in transfusion medicine. The Fresenius Helios segment operates approximately 112 hospitals, including 88 acute care hospitals and 24 post-acute care clinics; 78 outpatient clinics; 4 out-patient post-acute care centers; 18 prevention centers; and 13 nursing homes. This segment has approximately 35,000 beds. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as provides maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg, Germany.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *